New Model to Study Clot Lysis with Thrombolytic Drugs
Author Information
Author(s): Prasad Sweta, Kashyap Rajpal S, Deopujari Jayant Y, Purohit Hemant J, Taori Girdhar M, Daginawala Hatim F
Primary Institution: Central India Institute of Medical Sciences
Hypothesis
Can a new in vitro model effectively study the clot lysis activity of thrombolytic drugs like streptokinase?
Conclusion
The study presents a rapid and effective methodology to assess the clot-lytic effect of thrombolytic drugs.
Supporting Evidence
- Streptokinase showed significant clot lysis compared to water.
- The study developed a cost-effective model for measuring clot lysis.
- Different dilutions of streptokinase were tested for their efficacy.
Takeaway
Researchers created a simple test to see how well a medicine called streptokinase can dissolve blood clots.
Methodology
Whole blood from healthy individuals was used to form clots in microcentrifuge tubes, which were then treated with streptokinase to measure clot lysis.
Potential Biases
Potential bias in selecting healthy volunteers without a history of anticoagulant therapy.
Limitations
The study only tested one thrombolytic drug and used a limited sample size.
Participant Demographics
Healthy individuals without a history of oral contraceptive or anticoagulant therapy.
Statistical Information
P-Value
0.004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website